Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Edmonton
Clinical trial register · Canada

Clinical Trials in Edmonton, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6567 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:20 UTC
6567
Studies in scope
all four open statuses
3485
Recruiting now
open to new participants
883
Lead sponsors
across recruiting studies
Top sites
Montreal 71 Toronto 70 Québec 31 Edmonton 26 Calgary 21

Trials with a site in Edmonton

26 of 6567 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Calgary, Edmonton, Halifax, London, Toronto, Montreal, Québec, Sherbrooke
2026-01-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Edmonton, Oshawa, Toronto, Chicoutimi, Montreal, Québec, Saskatoon
2025-03-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Calgary, Edmonton, Vancouver, Winnipeg, Moncton, Halifax, Hamilton, Kingston
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Calgary, Edmonton, Lethbridge, New Westminster, Vancouver, Kentville, Barrie, London
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Edmonton, Ottawa, Toronto, Greenfield Park, Montreal, Québec, Sherbrooke
2023-12-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Edmonton, Abbotsford British Columbia, Mississauga, Ottawa, Toronto, Montreal, Québec
2023-12-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
868
Edmonton, Brampton, Toronto, Montreal
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
710
Calgary, Edmonton, Vancouver, Mississauga, Chicoutimi, Montreal
2023-12-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Calgary, Edmonton, Lethbridge, New Westminster, Vancouver, Kentville, Barrie, London
2023-10-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Edmonton, Vancouver, Brampton, Toronto, Montreal, Québec
2023-07-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Edmonton, Toronto, Sherbrooke
2023-05-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Edmonton, Kelowna, Vancouver, Toronto, Montreal, Saskatoon
2022-02-03
Recruiting
Merck Sharp & Dohme LLC
Phase 1
830
Edmonton, Moncton, Hamilton, Kingston, Toronto
2021-12-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Calgary, Edmonton, Hamilton
2021-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Calgary, Edmonton, Vancouver, Moncton, Hamilton, Kingston, Ottawa, Toronto
2021-02-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Edmonton, Toronto, Montreal, Sherbrooke
2018-12-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Edmonton, Winnipeg, Moncton, Ottawa, Toronto, Montreal, Québec
2018-09-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Calgary, Edmonton, Winnipeg, Hamilton, Kingston, London, Ottawa, Toronto
2018-08-21
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-canada/city/edmonton

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,567 studies in total at the last sync on 17 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Edmonton that also match the filters currently applied.

How many clinical trials are recruiting in Edmonton?

13 of the 26 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 13 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Edmonton), 26 studies
PhaseStudiesRecruitingShare
Phase 321980.8%
Phase 1/2217.7%
Observational113.8%
Phase 1113.8%
Phase 2/3113.8%

Most active sponsors

Lead sponsors with the most studies (Edmonton)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC2613
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.